Another study by Yoo et al., has shown that CSCs (CD133+CD44+) sorted out from human colon cancer cell lines that were resistant to the drug CPT11, were highly susceptible to an oncolytic vaccinia virus [117]. Here, PROM1 is linked to colonic neoplasm.